ZA201409073B - Compositions and methods for treating or preventing pneumovirus infection and associated diseases - Google Patents
Compositions and methods for treating or preventing pneumovirus infection and associated diseasesInfo
- Publication number
- ZA201409073B ZA201409073B ZA2014/09073A ZA201409073A ZA201409073B ZA 201409073 B ZA201409073 B ZA 201409073B ZA 2014/09073 A ZA2014/09073 A ZA 2014/09073A ZA 201409073 A ZA201409073 A ZA 201409073A ZA 201409073 B ZA201409073 B ZA 201409073B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- treating
- methods
- associated diseases
- pneumovirus infection
- Prior art date
Links
- 208000004692 Pneumovirus Infections Diseases 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261666258P | 2012-06-29 | 2012-06-29 | |
| PCT/US2013/048723 WO2014005098A2 (en) | 2012-06-29 | 2013-06-28 | Compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201409073B true ZA201409073B (en) | 2016-08-31 |
Family
ID=49778754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2014/09073A ZA201409073B (en) | 2012-06-29 | 2014-12-10 | Compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US9040569B2 (enExample) |
| EP (1) | EP2867216A4 (enExample) |
| JP (1) | JP2015524391A (enExample) |
| KR (1) | KR20150037946A (enExample) |
| CN (1) | CN104507918A (enExample) |
| AU (1) | AU2013282286A1 (enExample) |
| BR (1) | BR112014032290A2 (enExample) |
| CA (1) | CA2877941A1 (enExample) |
| EA (1) | EA201590124A1 (enExample) |
| HK (2) | HK1210163A1 (enExample) |
| IL (1) | IL236476A0 (enExample) |
| IN (1) | IN2014DN10680A (enExample) |
| MX (1) | MX2014015340A (enExample) |
| NZ (1) | NZ628880A (enExample) |
| TW (1) | TWI516283B (enExample) |
| WO (1) | WO2014005098A2 (enExample) |
| ZA (1) | ZA201409073B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015524391A (ja) | 2012-06-29 | 2015-08-24 | マイクロドース セラピューテクス，インコーポレイテッド | ニューモウイルス感染症および感染疾患を治療あるいは予防するための組成物および方法 |
| US10258620B2 (en) * | 2014-12-18 | 2019-04-16 | Metriopharm Ag | Crystalline form of 5-amino-2,3-dihydrophthalazine-1,4-dione sodium salt, pharmaceutical preparations containing the same and method for the production of said form |
| US20170151173A1 (en) * | 2015-11-30 | 2017-06-01 | Otic Pharma Inc. | Compositions and methods for otologic prophylaxis and treatment |
| WO2018071443A1 (en) | 2016-10-11 | 2018-04-19 | Microdose Therapeutx, Inc. | Inhaler and methods of use thereof |
| US20200085741A1 (en) * | 2018-09-14 | 2020-03-19 | Pharmosa Biopharm Inc. | Pharmaceutical composition for controlled release of weak acid drugs and uses thereof |
| CN109827875A (zh) * | 2019-04-10 | 2019-05-31 | 上海市食品药品检验所 | 一种用于测定吸入制剂溶出度的装置和方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6495580B1 (en) * | 1998-01-29 | 2002-12-17 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| EP1051169A4 (en) * | 1998-01-29 | 2002-05-29 | Viropharma Inc | COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING PNEUMOVIRAL INFECTIONS AND RELATED DISEASES |
| WO2002059132A1 (en) | 2001-01-26 | 2002-08-01 | Viropharma Incorporated | Intermediate compounds useful for making antiviral compounds |
| CA2495245A1 (en) | 2002-08-09 | 2004-02-19 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| CA2495266A1 (en) | 2002-08-09 | 2004-02-19 | Viropharma Incorporated | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
| JP2015524391A (ja) | 2012-06-29 | 2015-08-24 | マイクロドース セラピューテクス，インコーポレイテッド | ニューモウイルス感染症および感染疾患を治療あるいは予防するための組成物および方法 |
-
2013
- 2013-06-28 JP JP2015520598A patent/JP2015524391A/ja not_active Withdrawn
- 2013-06-28 AU AU2013282286A patent/AU2013282286A1/en not_active Abandoned
- 2013-06-28 HK HK15110967.1A patent/HK1210163A1/xx unknown
- 2013-06-28 NZ NZ628880A patent/NZ628880A/en not_active IP Right Cessation
- 2013-06-28 WO PCT/US2013/048723 patent/WO2014005098A2/en not_active Ceased
- 2013-06-28 CA CA2877941A patent/CA2877941A1/en not_active Abandoned
- 2013-06-28 CN CN201380034589.0A patent/CN104507918A/zh active Pending
- 2013-06-28 HK HK15104634.7A patent/HK1203956A1/xx unknown
- 2013-06-28 KR KR20157002571A patent/KR20150037946A/ko not_active Withdrawn
- 2013-06-28 MX MX2014015340A patent/MX2014015340A/es unknown
- 2013-06-28 US US13/931,201 patent/US9040569B2/en not_active Expired - Fee Related
- 2013-06-28 EP EP13809282.0A patent/EP2867216A4/en not_active Withdrawn
- 2013-06-28 EA EA201590124A patent/EA201590124A1/ru unknown
- 2013-06-28 BR BR112014032290A patent/BR112014032290A2/pt not_active IP Right Cessation
- 2013-06-28 IN IN10680DEN2014 patent/IN2014DN10680A/en unknown
- 2013-07-01 TW TW102123484A patent/TWI516283B/zh not_active IP Right Cessation
-
2014
- 2014-12-10 ZA ZA2014/09073A patent/ZA201409073B/en unknown
- 2014-12-25 IL IL236476A patent/IL236476A0/en unknown
-
2015
- 2015-04-10 US US14/683,935 patent/US9504672B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EA201590124A1 (ru) | 2015-06-30 |
| HK1203956A1 (en) | 2015-11-06 |
| MX2014015340A (es) | 2015-03-05 |
| JP2015524391A (ja) | 2015-08-24 |
| US9040569B2 (en) | 2015-05-26 |
| CN104507918A (zh) | 2015-04-08 |
| AU2013282286A1 (en) | 2015-01-22 |
| IN2014DN10680A (enExample) | 2015-08-28 |
| IL236476A0 (en) | 2015-02-26 |
| TW201416093A (zh) | 2014-05-01 |
| KR20150037946A (ko) | 2015-04-08 |
| EP2867216A4 (en) | 2015-12-09 |
| US20150209328A1 (en) | 2015-07-30 |
| TWI516283B (zh) | 2016-01-11 |
| US20140005239A1 (en) | 2014-01-02 |
| US9504672B2 (en) | 2016-11-29 |
| EP2867216A2 (en) | 2015-05-06 |
| NZ628880A (en) | 2016-08-26 |
| WO2014005098A2 (en) | 2014-01-03 |
| BR112014032290A2 (pt) | 2017-06-27 |
| HK1210163A1 (en) | 2016-04-15 |
| WO2014005098A3 (en) | 2014-02-27 |
| CA2877941A1 (en) | 2014-01-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3292875T3 (en) | Compositions and methods for treating diseases | |
| IL238416A0 (en) | Preparations and methods for the treatment of diseases caused by protein pathology | |
| EP2817018A4 (en) | METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS | |
| HUE041553T2 (hu) | Lizoszomális tárolási betegségek (LSD) kezelése és génterápia | |
| PL2818483T3 (pl) | Kompozycja lecznicza do leczenia i/lub zapobiegania nowotworowi | |
| IL237528A0 (en) | Methods for preventing and treating preeclampsia | |
| EP2655334A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES | |
| IL229257A0 (en) | Preparations and methods for the treatment of diseases related to the retina of the eye | |
| PT2740793T (pt) | Composição de fármacos para o tratamento e/ou a prevenção de cancro | |
| WO2014052836A3 (en) | Methods and compositions for treating infection | |
| IL238177A0 (en) | Methods and preparations for the treatment of cancer | |
| ZA201404187B (en) | Compositions and methods for treating dental conditions | |
| IL234829A0 (en) | Methods and preparations for treating inflammation | |
| ZA201408055B (en) | Compositions and methods for the treatment of local pain | |
| ZA201408056B (en) | Compositions and methods for the treatment of mucositis | |
| EP2897689A4 (en) | COMPOSITIONS AND METHODS OF TREATING ALOPEZIA | |
| TWI559917B (en) | Methods and compositions for treating neurodegenerative diseases | |
| EP2869821A4 (en) | COMPOSITIONS AND METHODS FOR TREATING AND INHIBITING VIRAL INFECTIONS | |
| IL234606A0 (en) | Innovative methods and compounds for the treatment of diseases | |
| ZA201409073B (en) | Compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
| GB2505959B (en) | Textile treatment compounds and compositions | |
| ZA201503844B (en) | Compositions and methods for treating dental caries | |
| ZA201408062B (en) | Compositions and methods for the treatment of multiple sclerosis | |
| EP2934501A4 (en) | USES AND METHOD FOR THE TREATMENT OF LIVER DISEASES OR DRESSES | |
| ZA201408065B (en) | Compositions and methods for the treatment of diabetes |